# IKZF1

## Overview
IKZF1 is a gene that encodes the Ikaros family zinc finger 1 protein, a critical transcription factor involved in the regulation of hematopoiesis and immune system function. The Ikaros protein is characterized by its zinc finger domains, which facilitate DNA binding and protein interactions, classifying it as a zinc finger transcription factor. It plays a pivotal role in the differentiation and function of various immune cells, including T and B lymphocytes, dendritic cells, and monocytes. The gene is subject to alternative splicing, resulting in multiple isoforms that influence the protein's function and localization. Mutations and alterations in IKZF1 are associated with several hematological and immunological disorders, including B-cell acute lymphoblastic leukemia and primary immune deficiencies, highlighting its clinical significance (Gorzkiewicz2015Functions; Cytlak2018Ikaros; Kuehn2021IKAROSAssociated).

## Structure
The IKZF1 gene encodes the Ikaros protein, a transcription factor characterized by zinc finger domains that facilitate DNA binding. The primary structure of Ikaros includes multiple zinc finger motifs, with the longest isoform consisting of 519 amino acids. The N-terminal region contains four C2H2 zinc fingers, crucial for DNA binding, while the C-terminal region has two additional zinc fingers important for protein interactions (Payne2011Zinc; Schjerven2013Selective).

The secondary structure of these zinc fingers is dominated by alpha helices, which interact with DNA in the major groove. The C2H2 zinc finger motif is composed of two antiparallel β sheets and an α helix, with two cysteines and two histidines coordinating a zinc ion, providing structural rigidity (Payne2011Zinc).

The tertiary structure involves the folding of these domains to enable DNA interaction, with specific amino acids responsible for sequence-specific interactions. The quaternary structure of Ikaros allows it to form homodimers or heterodimers, facilitated by the C-terminal zinc fingers (Payne2011Zinc).

Ikaros undergoes post-translational modifications, such as phosphorylation, which can affect its DNA binding affinity and transcriptional regulation during the cell cycle (Payne2011Zinc). The gene produces multiple isoforms through alternative splicing, which affects the protein's function and localization (Fan2016The; Molnár1994The).

## Function
The IKZF1 gene encodes the Ikaros protein, a zinc finger-containing transcription factor crucial for hematopoiesis and immune system regulation. In healthy human cells, Ikaros is involved in the differentiation and function of various immune cells, including T and B lymphocytes, dendritic cells, and monocytes. It plays a significant role in lymphocyte development by regulating gene expression, chromatin remodeling, and transcriptional repression (Gorzkiewicz2015Functions; Cytlak2018Ikaros).

Ikaros is essential for the development of plasmacytoid dendritic cells (pDCs) and influences the production of key cytokines such as interferon-alpha (IFN-α) and interleukin-12 (IL-12), which are critical for immune responses. IKZF1 deficiency leads to a reduction in pDCs and non-classical monocytes, while conventional dendritic cells (cDC1) may expand (Cytlak2018Ikaros).

In the nucleus, Ikaros modulates lymphoid and myeloid gene expression and is involved in the activation of IL-10 gene expression in CD4+ T cells. It also influences antigen-receptor rearrangement and the transcription of genes like Cd4 and Cd8, which are crucial for T cell activation and immune response regulation (Gorzkiewicz2015Functions).

## Clinical Significance
Mutations and alterations in the IKZF1 gene, which encodes the transcription factor IKAROS, are associated with a range of hematological and immunological disorders. In B-cell acute lymphoblastic leukemia (B-ALL), somatic mutations such as intragenic deletions and missense mutations in the DNA-binding domain are common, particularly in BCR-ABL1-positive cases, where they occur in approximately 70% of patients. These mutations are linked to poor prognosis and often require intensive treatment regimens (Kuehn2021IKAROSAssociated; Mullighan2009Deletion).

Germline mutations in IKZF1 are associated with primary immune deficiencies, including common variable immunodeficiency (CVID) and combined immunodeficiency (CID). These mutations can lead to DNA binding haploinsufficiency or dominant negative effects, resulting in progressive loss of B cells, immunoglobulins, and increased susceptibility to infections and autoimmunity (Kuehn2021IKAROSAssociated; Eskandarian2019Assessing).

IKZF1 mutations are also linked to hematological malignancies such as T-cell acute lymphoblastic leukemia (T-ALL) and Burkitt lymphoma. In T-ALL, IKZF1 alterations are associated with an immature immunophenotype and poor prognosis (Simonin2021IKZF1). Additionally, gain-of-function variants in IKZF1 can cause immune dysregulation, characterized by inflammatory and autoimmune symptoms (Hoshino2022Gain-of-function).

## Interactions
IKZF1, also known as Ikaros, is a transcription factor that participates in various protein interactions crucial for DNA damage repair and gene regulation. In multiple myeloma, IKZF1 interacts with CtIP, a protein that promotes homologous recombination (HR) by initiating DNA double-strand break end resection. This interaction is essential for the DNA damage response pathway to favor HR over non-homologous end joining (Liu2022IKZF1).

IKZF1 also interacts with ubiquitin-specific protease 7 (USP7), which stabilizes IKZF1 by removing ubiquitin, thus preventing its degradation. This interaction is specific, as other deubiquitinating enzymes do not affect IKZF1 stability. The interaction between IKZF1 and USP7 is enhanced upon DNA damage, indicating a role in HR repair (Liu2022IKZF1).

In the context of T-cell acute lymphoblastic leukemia, IKZF1 cooperates with the transcription factor GFI1 to regulate gene expression. Although they do not directly interact in solution, they co-occupy nearby DNA binding sites at common target genes, suggesting a cooperative role in gene regulation (Sun2021GFI1).

IKZF1 is also involved in the degradation process mediated by lenalidomide, which enhances its binding to cereblon, a ubiquitin ligase, leading to its degradation. This interaction is specific to lenalidomide and involves a particular region of IKZF1 (Lu2014The).


## References


[1. (Cytlak2018Ikaros) Urszula Cytlak, Anastasia Resteu, Delfien Bogaert, Hye Sun Kuehn, Thomas Altmann, Andrew Gennery, Graham Jackson, Attila Kumanovics, Karl V. Voelkerding, Seraina Prader, Melissa Dullaers, Janine Reichenbach, Harry Hill, Filomeen Haerynck, Sergio D. Rosenzweig, Matthew Collin, and Venetia Bigley. Ikaros family zinc finger 1 regulates dendritic cell development and function in humans. Nature Communications, March 2018. URL: http://dx.doi.org/10.1038/s41467-018-02977-8, doi:10.1038/s41467-018-02977-8. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-02977-8)

[2. (Mullighan2009Deletion) Charles G. Mullighan, Xiaoping Su, Jinghui Zhang, Ina Radtke, Letha A.A. Phillips, Christopher B. Miller, Jing Ma, Wei Liu, Cheng Cheng, Brenda A. Schulman, Richard C. Harvey, I-Ming Chen, Robert J. Clifford, William L. Carroll, Gregory Reaman, W. Paul Bowman, Meenakshi Devidas, Daniela S. Gerhard, Wenjian Yang, Mary V. Relling, Sheila A. Shurtleff, Dario Campana, Michael J. Borowitz, Ching-Hon Pui, Malcolm Smith, Stephen P. Hunger, Cheryl L. Willman, and James R. Downing. Deletion ofikzf1and prognosis in acute lymphoblastic leukemia. New England Journal of Medicine, 360(5):470–480, January 2009. URL: http://dx.doi.org/10.1056/nejmoa0808253, doi:10.1056/nejmoa0808253. This article has 1112 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/nejmoa0808253)

[3. (Molnár1994The) Árpád Molnár and Katia Georgopoulos. The ikaros gene encodes a family of functionally diverse zinc finger dna-binding proteins. Molecular and Cellular Biology, 14(12):8292–8303, December 1994. URL: http://dx.doi.org/10.1128/mcb.14.12.8292-8303.1994, doi:10.1128/mcb.14.12.8292-8303.1994. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.12.8292-8303.1994)

4. (Sun2021GFI1) GFI1 cooperates with IKAROS/IKZF1 to activate gene expression in T-cell acute lymphoblastic leukemia. This article has 0 citations.

[5. (Fan2016The) Yingzhi Fan and Duo Lu. The ikaros family of zinc-finger proteins. Acta Pharmaceutica Sinica B, 6(6):513–521, November 2016. URL: http://dx.doi.org/10.1016/j.apsb.2016.06.002, doi:10.1016/j.apsb.2016.06.002. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.apsb.2016.06.002)

[6. (Kuehn2021IKAROSAssociated) Hye Sun Kuehn, Cristiane J. Nunes-Santos, and Sergio D. Rosenzweig. Ikaros-associated diseases in 2020: genotypes, phenotypes, and outcomes in primary immune deficiency/inborn errors of immunity. Journal of Clinical Immunology, 41(1):1–10, January 2021. URL: http://dx.doi.org/10.1007/s10875-020-00936-x, doi:10.1007/s10875-020-00936-x. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-020-00936-x)

[7. (Eskandarian2019Assessing) Zoya Eskandarian, Manfred Fliegauf, Alla Bulashevska, Michele Proietti, Rosie Hague, Cristian Roberto Smulski, Desirée Schubert, Klaus Warnatz, and Bodo Grimbacher. Assessing the functional relevance of variants in the ikaros family zinc finger protein 1 (ikzf1) in a cohort of patients with primary immunodeficiency. Frontiers in Immunology, April 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.00568, doi:10.3389/fimmu.2019.00568. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.00568)

[8. (Hoshino2022Gain-of-function) Akihiro Hoshino, David Boutboul, Yuan Zhang, Hye Sun Kuehn, Jerôme Hadjadj, Nihal Özdemir, Tiraje Celkan, Christoph Walz, Capucine Picard, Christelle Lenoir, Nizar Mahlaoui, Christoph Klein, Xiao Peng, Antoine Azar, Erin Reigh, Morgane Cheminant, Alain Fischer, Frédéric Rieux-Laucat, Isabelle Callebaut, Fabian Hauck, Joshua Milner, Sergio D. Rosenzweig, and Sylvain Latour. Gain-of-function ikzf1 variants in humans cause immune dysregulation associated with abnormal t/b cell late differentiation. Science Immunology, March 2022. URL: http://dx.doi.org/10.1126/sciimmunol.abi7160, doi:10.1126/sciimmunol.abi7160. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciimmunol.abi7160)

[9. (Payne2011Zinc) Marvin A Payne. Zinc finger structure-function in ikaros marvin a payne. World Journal of Biological Chemistry, 2(6):161, 2011. URL: http://dx.doi.org/10.4331/wjbc.v2.i6.161, doi:10.4331/wjbc.v2.i6.161. This article has 23 citations.](https://doi.org/10.4331/wjbc.v2.i6.161)

[10. (Gorzkiewicz2015Functions) Anna Gorzkiewicz and Anna Walczewska. Functions of the ikaros transcription factor and the role of ikzf1 gene defects in hematological malignancies. Acta Haematologica Polonica, 46(1):10–19, January 2015. URL: http://dx.doi.org/10.1016/j.achaem.2014.10.001, doi:10.1016/j.achaem.2014.10.001. This article has 2 citations.](https://doi.org/10.1016/j.achaem.2014.10.001)

[11. (Schjerven2013Selective) Hilde Schjerven, Jami McLaughlin, Teresita L Arenzana, Seth Frietze, Donghui Cheng, Sarah E Wadsworth, Gregory W Lawson, Steven J Bensinger, Peggy J Farnham, Owen N Witte, and Stephen T Smale. Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of ikaros. Nature Immunology, 14(10):1073–1083, September 2013. URL: http://dx.doi.org/10.1038/ni.2707, doi:10.1038/ni.2707. This article has 90 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ni.2707)

[12. (Liu2022IKZF1) Meng Liu, Ying Zhang, Yunzhao Wu, Jin Jin, Yang Cao, Zhixiao Fang, Lou Geng, Li Yang, Miao Yu, Zhilei Bu, Yanjie Ji, Huizhuang Shan, Zhihui Zou, Ligen Liu, Yingying Wang, Youping Zhang, Yin Tong, Hanzhang Xu, Hu Lei, Wei Liu, Fenghou Gao, and Yingli Wu. Ikzf1 selectively enhances homologous recombination repair by interacting with ctip and usp7 in multiple myeloma. International Journal of Biological Sciences, 18(6):2515–2526, 2022. URL: http://dx.doi.org/10.7150/ijbs.70960, doi:10.7150/ijbs.70960. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.70960)

[13. (Lu2014The) Gang Lu, Richard E. Middleton, Huahang Sun, MarkVic Naniong, Christopher J. Ott, Constantine S. Mitsiades, Kwok-Kin Wong, James E. Bradner, and William G. Kaelin. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of ikaros proteins. Science, 343(6168):305–309, January 2014. URL: http://dx.doi.org/10.1126/science.1244917, doi:10.1126/science.1244917. This article has 1197 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1244917)

[14. (Simonin2021IKZF1) Mathieu Simonin, Ludovic Lhermitte, Marie-Emilie Dourthe, Etienne Lengliné, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Isabelle Arnoux, Virginie Gandemer, Norbert Ifrah, Hervé Dombret, André Baruchel, Elizabeth Macintyre, Arnaud Petit, Nicolas Boissel, and Vahid Asnafi. Ikzf1 alterations predict poor prognosis in adult and pediatric t-all. Blood, 137(12):1690–1694, March 2021. URL: http://dx.doi.org/10.1182/blood.2020007959, doi:10.1182/blood.2020007959. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.2020007959)